SFM
Sphera Funds Management’s Neurocrine Biosciences NBIX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q1 | – | Sell |
-37,000
| Closed | -$2.87M | – | 124 |
|
2017
Q4 | $2.87M | Sell |
37,000
-50,000
| -57% | -$3.88M | 0.34% | 72 |
|
2017
Q3 | $5.33M | Buy |
87,000
+25,000
| +40% | +$1.53M | 0.76% | 31 |
|
2017
Q2 | $2.85M | Sell |
62,000
-88,000
| -59% | -$4.05M | 0.48% | 57 |
|
2017
Q1 | $6.5M | Buy |
+150,000
| New | +$6.5M | 1.27% | 12 |
|
2016
Q2 | – | Sell |
-70,000
| Closed | -$2.77M | – | 96 |
|
2016
Q1 | $2.77M | Buy |
+70,000
| New | +$2.77M | 0.6% | 29 |
|
2015
Q2 | – | Sell |
-75,000
| Closed | -$2.98M | – | 141 |
|
2015
Q1 | $2.98M | Buy |
75,000
+25,000
| +50% | +$993K | 0.31% | 73 |
|
2014
Q4 | $1.12M | Buy |
+50,000
| New | +$1.12M | 0.19% | 101 |
|